Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics and head of the Aran Lab at Keck Graduate Institute (KGI) as well as Chief Scientific Officer of Cardea Bio, reacts to the announcement by stating, “I would like to express my heartfelt appreciation to all my colleagues and collaborators who have helped me turn my ideas and visions into technology and products that can make a true impact for humankinds. Being recognized as a top female founder motivates me to continue pushing the boundaries of science and technology.”
One of Kiana Aran’s innovations - the SNP-chip for amplification free DNA testing - was named as a Top 10 Innovation of 2021 by The Scientist magazine. After winning the 2021 Nature Research Award for Inspiring Women in Science, in 2022 Dr. Aran was the second woman since 1960 to receive Rutgers University’s Distinguished Engineer, Medal of Excellence award.
In addition, Dr. Aran was also selected in 2022 for a $1.6M grant from the National Institutes of Health (NIH) to help develop CRISPR Quality Control standards for therapeutics applications in this groundbreaking area of science. An area that holds the potential to treat or cure diseases, that are otherwise very harmful or even fatal for the patients.
Michael Heltzen, CEO at Cardea Bio, adds, “It is a pleasure to experience the startup community acknowledging and supporting Dr. Aran’s tremendous achievements. She has been instrumental in developing our BPU (Biosignal Processing Unit) platform and exciting applications using the BPU, including the CRISPR-chip. What is most inspiring about Dr. Aran, though, is her constant flow of innovations and endless positive energy!"